Mortality and Real Cause of Death from the Nonlesional Intracerebral Hemorrhage.
- Author:
Ki Dae KIM
1
;
Chul Hoon CHANG
;
Byung Yon CHOI
;
Young Jin JUNG
Author Information
- Publication Type:Original Article
- Keywords: Intracerebral hemorrhage; Cause of death
- MeSH: Cause of Death*; Cerebral Hemorrhage*; Diabetes Mellitus; Early Ambulation; Glasgow Coma Scale; Hemorrhage; Hospitalization; Humans; Immobilization; Mortality*; Pneumonia; Prospective Studies; Retrospective Studies; Stroke
- From:Journal of Korean Neurosurgical Society 2014;55(1):1-4
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: The case fatality rate of nonlesional intracerebral hemorrhage (n-ICH) was high and not changed. Knowing the causes is important to their prevention; however, the reasons have not been studied. The aims of this study were to determine the cause of death, to improve the clinical outcomes. METHODS: We retrospectively analyzed consecutive cases of nonlesional intracerebral hemorrhage in a prospective stroke registry from January 2010 to December 2010. RESULTS: Among 174 patients (61.83+/-13.36, 28-90 years), 29 patients (16.7%) died during hospitalization. Most common cause of death was initial neurological damage (41.4%, 12/29). Seventeen patients who survived the initial damage may then develop various potentially fatal complications. Except for death due to the initial neurological sequelae, death associated with immobilization (such as pneumonia or thromboembolic complication) was the most common in eight cases (8/17, 47.1%). However, death due to early rebleeding was not common and occurred in only 2 cases (2/17, 11.8%). Age, initial Glasgow Coma Scale, and diabetes mellitus were statistically significant factors influencing mortality (p<0.05). CONCLUSION: Mortality of n-ICH is still high. Initial neurological damage is the most important factor; however, non-neurological medical complications are a large part of case fatality. Most cases of death of patients who survived from the first bleeding were due to complications of immobilization. These findings have implications for clinical practice and planning of clinical trials. In addition, future conduct of a randomized study will be necessary in order to evaluate the benefits of early mobilization for prevention of immobilization related complications.
